Market Cap : 2.66 B | Enterprise Value : 2.22 B | PE Ratio : 26.69 | PB Ratio : 5.08 |
---|
NAS:CORT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CORT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Corcept Therapeutics's purchase of investment for the three months ended in Dec. 2020 was $-97.0 Mil. It means Corcept Therapeutics spent $97.0 Mil on purchasing investments. Corcept Therapeutics's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2020 was $-420.1 Mil.
Compared with last quarter ($-103.8 Mil in Sep. 2020 ), Corcept Therapeutics spent less money on purchasing investments in Dec. 2020 ($-97.0 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
Purchase of Investments represents cash outflow on the purchase of investments in securities.
Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2020 was -48.469 (Mar. 2020 ) + -170.845 (Jun. 2020 ) + -103.78 (Sep. 2020 ) + -97.02 (Dec. 2020 ) = $-420.1 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
No Headline